Deramciclane
Alternative Names: Deramciclane fumarate; EGIS-3886; EGYT 3886Latest Information Update: 26 Feb 2003
Price :
$50 *
At a glance
- Originator Egis Pharmaceuticals
- Developer Orion; Pharmacia Corporation
- Class Anxiolytics; Ethylamines; Small molecules
- Mechanism of Action GABA uptake inhibitors; Serotonin 2C receptor inverse agonists; Serotonin 5-HT2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Generalised anxiety disorder
Most Recent Events
- 19 Feb 2003 Discontinued - Phase-III for Generalised anxiety disorder in Europe (PO)
- 19 Feb 2003 Discontinued - Phase-III for Generalised anxiety disorder in Finland (PO)
- 19 Feb 2003 Discontinued - Phase-III for Generalised anxiety disorder in South Africa (PO)